CONTINUATION RATE OF IMMEDIATE POSTPARTUM INSERTION OF INTRAUTERINE CONTRACEPTIVE DEVICE.

JPUMHS;2024:14:01,109-114. http://doi.org/10.46536/jpumhs/2024/14.01.503

Abstract

BACKGROUND: Contraception methods are designed to prevent undesired pregnancies on a temporary or
permanent basis. An intrauterine contraceptive device such as Cu-T-380A offers contraception for a duration of
up to 10 years. Traditionally, the initiation of postpartum birth control has been postponed until the 6-week
postpartum visit. Women are typically advised to abstain from sexual activity until the 6-week postpartum period
as part of their discharge instructions from the hospital. OBJECTIVE: To determine the frequency of
continuation rate of postpartum insertion of intrauterine contraceptive device in women delivering at Lady
Reading Hospital, Peshawar. STUDY DESIGN & SETTING: Descriptive study conducted at the Department of
Obstetrics and Gynecology, Lady Reading Hospital, Peshawar. METHODOLOGY: The study was conducted
between September 1, 2021, and February 28, 2022. A total of 104 pregnant women who were counseled for
(PPIUCD) insertion during antenatal care or early labor and expressed willingness to have an IUD inserted after
delivery were recruited for the study. Participants were followed up at six weeks and six months postpartum.
RESULTS: The continuation rate of postpartum insertion of the intrauterine contraceptive devices was noted.
The age range in this study was from 25 to 40 years with a mean age of 30.836±2.91 years and a mean gestational
age was 38.61±1.20weeks. The continuation rate of IUD was observed in 91.3% of patients. CONCLUSION: In
conclusion, the findings of this study indicate highly satisfactory continuation rates for PPCuIUD at 6 months.
The research explores recent developments that have expanded accessibility to all intrauterine devices (IUDs) and
provides detailed descriptions of each IUD's features. Despite the notable increase in IUD usage, potential
complications related to IUD placement may still arise. Therefore, ongoing updates on strategies to mitigate these
IUD-related issues are essential.